HB1921, titled the Hearing Device Coverage Clarification Act, would require the Administrator of the Centers for Medicare & Medicaid Services (CMS) to clarify within 60 days of enactment that fully implanted active middle ear hearing devices are considered prosthetics under Medicare. The bill specifically states that these devices would not be subject to Medicare’s hearing aid coverage exclusion under section 1862(a)(7) of the Social Security Act.
In practical terms, the measure is aimed at ensuring Medicare coverage treatment for a specific category of implanted hearing technology. It does not create a new benefit category so much as direct CMS to interpret existing law and regulations in a way that distinguishes these devices from excluded hearing aids. The bill also defines “prosthetic” by reference to existing federal regulations at 42 C.F.R. 414.202.
Impact
If enacted, the bill would affect Medicare coverage policy by requiring CMS to formally classify fully implanted active middle ear hearing devices as prosthetics rather than hearing aids for purposes of the Medicare exclusion. That would likely expand access to coverage for eligible beneficiaries who use these devices and could influence reimbursement decisions, claims processing, and provider billing under the Medicare program. The bill would not directly amend the Social Security Act text, but it would direct an agency clarification that would shape how the existing hearing-aid exclusion is applied.
Sentiment
Available context suggests generally supportive sentiment, or at least low controversy, around the bill. The measure was introduced by Representatives Fischbach and Craig, indicating bipartisan sponsorship, and there are no recorded committee transcripts or votes showing opposition or debate in the provided materials. The bill’s narrow focus on coverage clarification for a specific medical device suggests it is framed as a technical Medicare policy fix rather than a broader partisan issue.
Contention
The main potential point of contention is whether fully implanted active middle ear hearing devices should be treated as prosthetics eligible for Medicare coverage or as hearing aids excluded from coverage under current law. Any disagreement would likely center on statutory interpretation, budgetary effects on Medicare spending, and whether the bill creates a precedent for other hearing-related devices. However, the provided materials do not show any explicit objections, amendments, or recorded opposition.